ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $25,000 | -60.9% | 11,000 | -41.2% | 0.00% | -66.7% |
| Q1 2017 | $64,000 | 0.0% | 18,698 | +24.7% | 0.01% | -10.0% |
| Q3 2016 | $64,000 | +36.2% | 15,000 | -23.1% | 0.01% | +25.0% |
| Q2 2016 | $47,000 | -25.4% | 19,500 | +44.4% | 0.01% | -27.3% |
| Q1 2016 | $63,000 | -3.1% | 13,500 | -18.3% | 0.01% | -8.3% |
| Q4 2015 | $65,000 | +30.0% | 16,533 | +26.9% | 0.01% | +20.0% |
| Q3 2015 | $50,000 | -2.0% | 13,033 | +18.1% | 0.01% | +11.1% |
| Q2 2015 | $51,000 | – | 11,033 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |